D. Peers

发表

Modification of CD4 immunoadhesin with monomethoxypoly(ethylene glycol) aldehyde via reductive alkylation.

S. Shak, M. Venuti, A. Ashkenazi, 1994, Bioconjugate chemistry.

Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent.

A. Ashkenazi, S. Chamow, R. Byrn, 1992, The Journal of biological chemistry.

Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins

J. Lofgren, P. Berman, V. Chisholm, 1999, Nature Biotechnology.

Secretion of glycosylation site mutants can be rescued by the signal/pro sequence of tissue plasminogen activator

T. Ryll, P. Berman, S. Chamow, 1999, Journal of cellular biochemistry.

Vascular endothelial growth factor is essential for corpus luteum angiogenesis

Kenneth J. Hillan, Napoleone Ferrara, K. Hillan, 1998, Nature Medicine.

A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.

S. Marsters, A. Ashkenazi, S. Chamow, 1994, Journal of hematotherapy.

Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments.

P. Bjorkman, A. Ashkenazi, M. Mulkerrin, 1990, Biochemistry.

Inhibition of interferon-gamma by an interferon-gamma receptor immunoadhesin.

S. Marsters, A. Ashkenazi, S. Chamow, 1993, Immunology.